Bonumose

What is Bonumose?

Bonumose LLC, which has developed and patented an enzymatic technology platform for continuous production of high-purity rare sugars – such as tagatose and allulose – from low-cost, plant-based feedstocks (starch).

Rare sugars have the potential to significantly disrupt the global sweetener market in both consumer and processed food applications. Bonumose’s lead products, tagatose and allulose, taste like sugar, have significantly fewer calories than normal sugar, have negligible glycemic index, are non-cariogenic and perform like normal sugar in major applications such as baking, confectionary, beverages and frozen desserts. These rare sugars are well known by the global food industry, but prior to Bonumose’s patented technology and process, they were never cost effective enough for widespread application.

Bonumose’s mission is to “democratize nutritious sugar”. Bonumose CEO Ed Rogers said, “We created Bonumose as a new company in 2016 for the purpose of commercializing our enzymatic technology breakthrough to produce affordable, delicious, healthy tagatose. Since then, Bonumose has developed methods for producing additional affordable healthy sugars, such as allulose, allose, mannose, and inositol.”

In addition to commodity starch, Bonumose’s process also can use by-product/side-stream starch left over from plant-based protein production such as pea protein and potato protein. By using starch as the food stock, Bonumose has a strong environmental impact by upcycling otherwise wasted food streams. Bonumose biproducts can also be used in other foods creating a true “circular economy” company.